search
Back to results

Somatocognitive Therapy in Treatment of Provoked Vestibulodynia - a Feasibility Study (ProLoVe)

Primary Purpose

Provoked Vestibulodynia

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
somatocognitive physiotherapy
Sponsored by
Oslo Metropolitan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Provoked Vestibulodynia focused on measuring provoked localized vulvodynia, provoked vestibulodynia, vestibulitt, physiotherapy

Eligibility Criteria

18 Years - 35 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Confirmed provoked vestibulodynia diagnosis

Exclusion Criteria:

  • vulvar pain is not clearly linked to intercourse or pressure applied to vestibule or usage of tampon
  • active infection or dermatologic lesion in the vulvar region

Sites / Locations

  • Oslo Metropolitan University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Somatocognitive physiotherapy

Arm Description

Every participant will maximally receive 15 individual sessions of somatocognitive physiotherapy

Outcomes

Primary Outcome Measures

Recruitment rate
Number of eligible patients and number of recruited participants per week
Follow-up rate
The follow-up rate is measured by the percentage of participants who were followed up successfully until the 8 months follow-up
Adherence
Adherence is defined as the number of participants who fully complete the battery of self-report questionnaires, 14-day diary, biweekly forms about the received treatment and perform Tampon tests.
Evaluation of Tampon test as a primary outcome measure - score variance
Participants perform Tampon test 3 times in course of 14 days (day1, 7 and 14) at each of the 3 time points (baseline, post-treatment, 8 months after baseline), 9 scores in total. Numerical rating scale (0-10) will be used to score pain intensity. Intra-individual score variance will be estimated as difference between the min and max score at each time point for every participant. Lower variability is better.
Adverse events
If participant is pulled out of the study because somatocognitive therapy is deemed as a non-appropriate treatment (e.g. participant is instead referred to psychological counselling), such event is recorded as adverse.
Evaluation of Tampon test as a primary outcome measure - qualitative interviews
All participants are asked in individual qualitative interviews if they experience a Tampon test as a relevant instrument for assessing pain sensitivity experienced during intercourse.

Secondary Outcome Measures

Implementation and acceptability of the somatocogntive therapy intervention
Participants will be asked in qualitative interviews about their experiences with somatocogntitve therapy intervention. Global Rating of Change scale will be used to provide quantitative estimation of participants' satisfaction with the treatment effect directly after treatment and at 8 months follow-up. The scale ranges from 1 to 6. Score of 1 means that treatment helped a lot and the score of 6 means that the treatment made the condition much worse.
Evaluation of somatocognitive therapy intervention's potential to reduce pain
Changes in individual mean scores (0-10, the lower score the better) of pain experienced during tampon test between 3 measurements time points.
Evaluation of somatocognitive therapy intervention's potential to improve sexual functioning
Changes in individual scores on Female Sexual Function Index between 3 measurements time points. Scale ranges 0-36, higher score means better sexual functioning.
Evaluation of somatocognitive therapy intervention's potential to reduce psychological distress
Changes in individual scores on Hopkins Symptom Check List - 25 questions version between 3 measurements time points. Scale ranges 1-4, lower score indicates less psychological distress.
Evaluation of somatocognitive therapy intervention's potential to reduce pain catastrophizing
Changes in individual scores on Pain Catastrophizing Scale between 3 different time points. Scale ranges 0-52, the lower score represents less pain catastrophizing

Full Information

First Posted
October 30, 2019
Last Updated
September 29, 2020
Sponsor
Oslo Metropolitan University
Collaborators
Oslo University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04208204
Brief Title
Somatocognitive Therapy in Treatment of Provoked Vestibulodynia - a Feasibility Study
Acronym
ProLoVe
Official Title
Somatocognitive Therapy in Treatment of Provoked Vestibulodynia - Process of Change and User Experience
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
February 1, 2019 (Actual)
Primary Completion Date
July 31, 2020 (Actual)
Study Completion Date
July 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Oslo Metropolitan University
Collaborators
Oslo University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study examines feasibility of R&D activities in the planned randomized controlled trial where effectiveness of somatocognitive therapy intervention will be compared to treatment as usual in provoked vestibulodynia.
Detailed Description
Provoked vestibulodynia is a multifactorial, persistent pain condition, affecting young women. It represents the most common cause of pain during sexual intercourse. Existing treatment approaches are predominantly based on clinical experience, observational studies, or reports of expert committees. Although, physiotherapy is one of the most commonly recommended treatments, high quality randomized controlled trials are needed to assess its effectiveness. This is a phase I, feasibility study with the purpose of testing R&D activities for a planned full size RCT. Additionally, patients experiences with the somatocognitive therapy intervention, assessment measures and condition itself will be collected using qualitative interviews. The results will be applied to adjust time-line of the treatment, outcome measures and therapeutic approach before commencing full scale RCT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Provoked Vestibulodynia
Keywords
provoked localized vulvodynia, provoked vestibulodynia, vestibulitt, physiotherapy

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Three measurements time points: baseline, after treatment, and 8 months after baseline. Additionally two interviews per participant; first - between baseline and treatment ending and second after 8 months follow up
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Somatocognitive physiotherapy
Arm Type
Experimental
Arm Description
Every participant will maximally receive 15 individual sessions of somatocognitive physiotherapy
Intervention Type
Other
Intervention Name(s)
somatocognitive physiotherapy
Intervention Description
Somatocognitive physiotherapy (SCT) is a multimodal physical therapy approach that has been developed in an attempt at alleviating the burden of longstanding pain. The main foci of SCT include: (1) bodily exercises and techniques increasing body awareness, ability to relax and control muscle tension in different situations; (2) education about the vulvodynia and factors influencing pain experience; (3) coping with emotions and thoughts related to bodily experiences; and (4) structured homework assignments promoting application of the learned techniques in daily situation and gradual exposure to activities associated with pain. An important goal of SCT is to facilitate integration of new bodily habits into the patient's daily activities. The most important learning process thus occurs in the space between the treatment sessions. The therapeutic techniques are to be rehearsed in everyday situations.
Primary Outcome Measure Information:
Title
Recruitment rate
Description
Number of eligible patients and number of recruited participants per week
Time Frame
5 months
Title
Follow-up rate
Description
The follow-up rate is measured by the percentage of participants who were followed up successfully until the 8 months follow-up
Time Frame
8 months
Title
Adherence
Description
Adherence is defined as the number of participants who fully complete the battery of self-report questionnaires, 14-day diary, biweekly forms about the received treatment and perform Tampon tests.
Time Frame
8 months
Title
Evaluation of Tampon test as a primary outcome measure - score variance
Description
Participants perform Tampon test 3 times in course of 14 days (day1, 7 and 14) at each of the 3 time points (baseline, post-treatment, 8 months after baseline), 9 scores in total. Numerical rating scale (0-10) will be used to score pain intensity. Intra-individual score variance will be estimated as difference between the min and max score at each time point for every participant. Lower variability is better.
Time Frame
8 months
Title
Adverse events
Description
If participant is pulled out of the study because somatocognitive therapy is deemed as a non-appropriate treatment (e.g. participant is instead referred to psychological counselling), such event is recorded as adverse.
Time Frame
8 months
Title
Evaluation of Tampon test as a primary outcome measure - qualitative interviews
Description
All participants are asked in individual qualitative interviews if they experience a Tampon test as a relevant instrument for assessing pain sensitivity experienced during intercourse.
Time Frame
8 months
Secondary Outcome Measure Information:
Title
Implementation and acceptability of the somatocogntive therapy intervention
Description
Participants will be asked in qualitative interviews about their experiences with somatocogntitve therapy intervention. Global Rating of Change scale will be used to provide quantitative estimation of participants' satisfaction with the treatment effect directly after treatment and at 8 months follow-up. The scale ranges from 1 to 6. Score of 1 means that treatment helped a lot and the score of 6 means that the treatment made the condition much worse.
Time Frame
8 months
Title
Evaluation of somatocognitive therapy intervention's potential to reduce pain
Description
Changes in individual mean scores (0-10, the lower score the better) of pain experienced during tampon test between 3 measurements time points.
Time Frame
8 months
Title
Evaluation of somatocognitive therapy intervention's potential to improve sexual functioning
Description
Changes in individual scores on Female Sexual Function Index between 3 measurements time points. Scale ranges 0-36, higher score means better sexual functioning.
Time Frame
8 months
Title
Evaluation of somatocognitive therapy intervention's potential to reduce psychological distress
Description
Changes in individual scores on Hopkins Symptom Check List - 25 questions version between 3 measurements time points. Scale ranges 1-4, lower score indicates less psychological distress.
Time Frame
8 months
Title
Evaluation of somatocognitive therapy intervention's potential to reduce pain catastrophizing
Description
Changes in individual scores on Pain Catastrophizing Scale between 3 different time points. Scale ranges 0-52, the lower score represents less pain catastrophizing
Time Frame
8 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Confirmed provoked vestibulodynia diagnosis Exclusion Criteria: vulvar pain is not clearly linked to intercourse or pressure applied to vestibule or usage of tampon active infection or dermatologic lesion in the vulvar region
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Slawomir Wojniusz, PhD
Organizational Affiliation
Oslo Metropolitan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oslo Metropolitan University
City
Oslo
ZIP/Postal Code
0130
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35321744
Citation
Kaarbo MB, Danielsen KG, Haugstad GK, Helgesen ALO, Wojniusz S. Feasibility and acceptability of somatocognitive therapy in the management of women with provoked localized vestibulodynia-ProLoVe feasibility study. Pilot Feasibility Stud. 2022 Mar 23;8(1):68. doi: 10.1186/s40814-022-01022-2.
Results Reference
derived
PubMed Identifier
33967000
Citation
Kaarbo MB, Danielsen KG, Haugstad GK, Helgesen ALO, Wojniusz S. The Tampon Test as a Primary Outcome Measure in Provoked Vestibulodynia: A Mixed Methods Study. J Sex Med. 2021 Jun;18(6):1083-1091. doi: 10.1016/j.jsxm.2021.03.010. Epub 2021 May 6.
Results Reference
derived

Learn more about this trial

Somatocognitive Therapy in Treatment of Provoked Vestibulodynia - a Feasibility Study

We'll reach out to this number within 24 hrs